(Q37996075)

26 August 2017

0 references

The relationship between drug clearance and body size: systematic review and meta-analysis of the literature published from 2000 to 2007. (English)

1 reference

26 August 2017

0 references

1 reference

Sarah C McLeay

1

1 reference

26 August 2017

Glynn A Morrish

series ordinal

2

1 reference

26 August 2017

Carl M J Kirkpatrick

series ordinal

3

1 reference

26 August 2017

Bruce Green

series ordinal

4

1 reference

26 August 2017

publication date

1 May 2012

1 reference

Clinical Pharmacokinetics

26 August 2017

published in

1 reference

26 August 2017

volume

51

1 reference

26 August 2017

issue

5

1 reference

26 August 2017

page(s)

319-330

1 reference

https://scigraph.springernature.com/pub.10.2165/11598930-000000000-00000

26 August 2017

exact match

0 references

cites work

Dosing in obesity: a simple solution to a big problem.

1 reference

https://api.crossref.org/works/10.2165%2F11598930-000000000-00000

What is the best size descriptor to use for pharmacokinetic studies in the obese?

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11598930-000000000-00000

Quantification of lean bodyweight.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11598930-000000000-00000

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11598930-000000000-00000

Effect of body surface area calculations on body fat estimates in non-obese and obese subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11598930-000000000-00000

Mechanism-based concepts of size and maturity in pharmacokinetics

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11598930-000000000-00000

A size standard for pharmacokinetics.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11598930-000000000-00000

21 January 2018

Body size and metabolism

1 reference

https://api.crossref.org/works/10.2165%2F11598930-000000000-00000

Mammalian basal metabolic rate is proportional to body mass2/3.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11598930-000000000-00000

Prediction of drug clearance in children: impact of allometric exponents, body weight, and age.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11598930-000000000-00000

Application of fixed exponent 0.75 to the prediction of human drug clearance: an inaccurate and misleading concept

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11598930-000000000-00000

Controversy in the allometric application of fixed- versus varying-exponent models: a statistical and mathematical perspective.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11598930-000000000-00000

Informative study designs to identify true parameter-covariate relationships.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11598930-000000000-00000

Are population pharmacokinetic and/or pharmacodynamic models adequately evaluated? A survey of the literature from 2002 to 2004.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11598930-000000000-00000

Fixed dosing versus body size-based dosing of monoclonal antibodies in adult clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11598930-000000000-00000

Overview of model-building strategies in population PK/PD analyses: 2002-2004 literature survey

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11598930-000000000-00000

Systematic comparison of the population pharmacokinetics and pharmacodynamics of piperacillin in cystic fibrosis patients and healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11598930-000000000-00000

Population pharmacokinetics of tolcapone in parkinsonian patients in dose finding studies

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11598930-000000000-00000

Ganciclovir population pharmacokinetics in neonates following intravenous administration of ganciclovir and oral administration of a liquid valganciclovir formulation

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11598930-000000000-00000

Population pharmacokinetics of darbepoetin alfa in healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11598930-000000000-00000

Orogastric and intravenous indomethacin administration to very premature neonates with patent ductus arteriosus: population pharmacokinetics, absolute bioavailability, and treatment outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11598930-000000000-00000

Population pharmacokinetics of oxaliplatin in patients with metastatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11598930-000000000-00000

Population pharmacokinetics of carbamazepine in Singapore epileptic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11598930-000000000-00000

Population pharmacokinetics of theophylline in very premature Japanese infants with apnoea

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11598930-000000000-00000

Imatinib pharmacokinetics in patients with gastrointestinal stromal tumour: a retrospective population pharmacokinetic study over time. EORTC Soft Tissue and Bone Sarcoma Group

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11598930-000000000-00000

Pharmacokinetic basis for the use of extended interval dosage regimens of gentamicin in neonates.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11598930-000000000-00000

In children, the addition of epinephrine modifies the pharmacokinetics of ropivacaine injected caudally

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11598930-000000000-00000

Effect of CYP2C19 genetic polymorphism on pharmacokinetics of phenytoin and phenobarbital in Japanese epileptic patients using Non-linear Mixed Effects Model approach.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11598930-000000000-00000

Caution when lean body weight is used as a size descriptor for obese subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11598930-000000000-00000

A formula to estimate the approximate surface area if height and weight be known. 1916.

21 January 2018

1 reference

12 December 2020

Simplified calculation of body-surface area.

1 reference

12 December 2020

The meaning and measurement of lean body mass

1 reference

12 December 2020

Power, selection bias and predictive performance of the Population Pharmacokinetic Covariate Model

1 reference

12 December 2020

1 reference

12 December 2020

Lean body mass as a metabolic reference standard

1 reference

12 December 2020

10.2165/11598930-000000000-00000

Identifiers

DOI

1 reference

Dimensions Publication ID

26 August 2017

1022314898

0 references

1 reference